Medicare Enrolled

Dr. Suneeta Pinnamaneni, MD

Medical Oncology · Leesburg, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
9832 US HIGHWAY 441, Leesburg, FL 34788
3527873341
In practice since 2008 (17 years)
NPI: 1265609580 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pinnamaneni from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pinnamaneni? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pinnamaneni

Dr. Suneeta Pinnamaneni is a medical oncology in Leesburg, FL, with 17 years in practice. Based on federal Medicare data, Dr. Pinnamaneni performed 39,872 Medicare services across 922 unique beneficiaries.

Between the years covered by Open Payments, Dr. Pinnamaneni received a total of $5,385 from 35 pharmaceutical and/or device companies across 220 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pinnamaneni is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ Top 37% volume in FL$ $5,385 industry payments

Medicare Practice Summary

Medicare Utilization ↗
39,872
Medicare services
Top 37% in FL for medical oncology
922
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,345 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Iron infusion (Injectafer)27,750$1$3
Anti-nausea injection (ondansetron/Zofran)3,500$0$2
Dexamethasone injection (steroid)3,410$0$1
Denosumab injection (Prolia/Xgeva)1,980$18$40
Office visit, established patient, complex (40-54 min)553$131$300
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less424$22$92
Blood draw (venipuncture)375$8$15
Office visit, established patient (30-39 min)326$96$220
Infusion, normal saline solution, sterile (500 ml = 1 unit)305$1$2
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional216$16$40
Administration of chemotherapy into vein, 1 hour or less173$97$275
Administration of chemotherapy into vein, each additional hour171$22$61
Infusion into a vein for hydration, each additional hour165$10$31
Drug injection, under skin or into muscle109$11$50
Injection, diphenhydramine hcl, up to 50 mg98$1$5
Administration of additional new drug or substance into vein, 1 hour or less82$48$140
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less57$48$142
New patient office visit, complex (60-74 min)53$150$425
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg48$1$8
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour45$16$43
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle32$55$150
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
72.1% high complexity
23.9% medium
4.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$5,385
Total received (2018-2024)
Avg $769/year across 7 years
Bottom 45% in FL for medical oncology
35
Companies
220
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,285 (79.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,100 (20.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,634
2023
$1,174
2022
$435
2021
$209
2020
$321
2019
$686
2018
$926

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$1,037
Medtronic, Inc.
$944
Novartis Pharmaceuticals Corporation
$560
E.R. Squibb & Sons, L.L.C.
$327
AstraZeneca Pharmaceuticals LP
$307
Astellas Pharma US Inc
$293
Daiichi Sankyo Inc.
$246
Janssen Biotech, Inc.
$207
SOBI, INC
$160
Regeneron Healthcare Solutions, Inc.
$155
Abbott Laboratories
$152
Merck Sharp & Dohme LLC
$144
Medtronic USA, Inc.
$101
PFIZER INC.
$96
Nevro Corp.
$92
Nuvectra Corporation
$75
Incyte Corporation
$54
Coherus Biosciences Inc.
$49
INSYS Therapeutics Inc
$45
ABBVIE INC.
$33
GENZYME CORPORATION
$31
Genentech USA, Inc.
$27
Celgene Corporation
$27
Merck Sharp & Dohme Corporation
$26
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
Amneal Pharmaceuticals LLC
$22
Upsher-Smith Laboratories LLC
$20
Alexion Pharmaceuticals, Inc.
$20
SPR Therapeutics, Inc
$18
Partner Therapeutics, Inc.
$17
Organon LLC
$17
ACCORD HEALTHCARE, INC.
$17
Seattle Genetics, Inc.
$15
CTI BioPharma Corp.
$15
BOSTON SCIENTIFIC CORPORATION
$15
Top 3 companies account for 47.2% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ALIMTA · ANDEXXA · Abraxane · Algovita · CAMCEVI · CYRAMZA · DARZALEX · DOPTELET · ELITEK · ENHERTU · ERLEADA · Enhertu · Erleada · GILOTRIF · Gazyva · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INTELLIS · INTELLIS ADAPTIVESTIM · JAKAFI · KEYTRUDA · KISQALI · LIBTAYO · LYNPARZA · Leukine · MEKINIST · NEUPOGEN · OPDIVO · PIQRAY · PLUVICTO · PROMACTA · Proclaim Family of SCS IPGs · QUDEXY XR Topiramate Extended Release Capsules · RETEVMO · Revlimid · SARCLISA · SCS IPGs · SOLIRIS · SPECTRA WAVEWRITER · SPRINT PNS System · SYNCHROMED · SYNDROS · Senza Spinal Cord Stimulation System · TASIGNA · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · Vanflyta · Vonjo · XTANDI · Xtandi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (80%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $14 per 100 Medicare services performed
Looking for a medical oncology in Leesburg?
Compare medical oncologys in the Leesburg area by procedure volume, costs, and industry payment transparency.
Browse medical oncologys nearby

Geographic Context

Medical Oncologys within 10 mi
7
Per 100K population
1.8
County median income
$69,956
Nearest hospital
VILLAGES REGIONAL HOSPITAL, THE
7.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Pinnamaneni is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Pinnamaneni experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Pinnamaneni performed 27,750 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pinnamaneni receive payments from pharmaceutical companies?
Yes. Dr. Pinnamaneni received a total of $5,385 from 35 companies across 220 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pinnamaneni's costs compare to other medical oncologys in Leesburg?
Dr. Pinnamaneni's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pinnamaneni) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →